Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
Monoclon Antib Immunodiagn Immunother ; 42(6): 194-202, 2023 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-38156888

RESUMEN

Graves' disease is the most common cause of thyrotoxicosis and is characterized by ophthalmopathy with proptosis, chemosis, or conjunctival injection; pretibial myxedema; and thyroid acropachy. It is an autoimmune disease that can be genetic or influenced by coexisting environmental factors such as exposure to anticancer drugs, including immune checkpoint inhibitors. The incidence rate of breast cancer is increasing due to rising awareness of risk factors and screening for breast cancer, and the mortality rate is decreasing due to recent advances in cancer treatment. However, there are side effects that are attributed to these treatment modalities, manifesting in various forms in breast cancer survivors, which are reflected in the patient in this case study.


Asunto(s)
Neoplasias de la Mama , Enfermedad de Graves , Mixedema , Femenino , Humanos , Persona de Mediana Edad , Neoplasias de la Mama/tratamiento farmacológico , Neoplasias de la Mama/complicaciones , Trastuzumab/efectos adversos , Anticuerpos Monoclonales , Enfermedad de Graves/diagnóstico , Enfermedad de Graves/tratamiento farmacológico , Enfermedad de Graves/complicaciones , Mixedema/complicaciones , Mixedema/terapia
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA